3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 34.60
-1.30 (-3.62%)
Apr 29, 2026, 1:25 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 2.76 billion as of April 28, 2026. Its market cap has decreased by -39.93% in one year.
Market Cap
2.76B
Enterprise Value
2.34B
Revenue
206.74M
Ranking
n/a
PE Ratio
42.74
Stock Price
34.60
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 2.76B, an increase of 1.00%. That is a compound annual growth rate of 0.19%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syngen Biotech | 2.82B |
| Sunhawk Vision Biotech | 2.70B |
| Apex Biotechnology | 2.88B |
| HeXun Biosciences | 2.92B |
| TWi Biotechnology | 2.63B |
| BRIM Biotechnology | 3.05B |
| Sinew Pharma | 2.48B |
| GlycoNex Incorporation | 2.45B |